ZP9830

Pipeline

Status by Indication[3][1]

Competition

Competitive Landscape

ARTPlaque Psoriasis

96 competitors in ART

#DrugCompanyPhaseTrials

1

Belamaf

GSK

Phase 3

32

Venclexta

AbbVie

Phase 3

23

Rituxan

Roche

Phase 3

14

Lorelco

Sanofi

Phase 3

15

Treanda

AAzurity Pharmaceuticals

Phase 3

16

Toradol

JJavelin Pharmaceuticals

Phase 3

17

Brukinsa

BBeOne Medicines

Phase 3

18

Attruby

NNavire Pharma Inc., a BridgeBio company

Phase 3

19

Cysteine Hydrochloride

Novartis

Phase 2

110

Noradrenaline

IInstitute of Liver and Biliary Sciences, India

Phase 3

1Show 32 more competitors

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Clinical

Trials by Indication[1]

ART1 trial

A Research Study Looking at the Safety of Single and Multiple Doses of ZP9830 and How it Works in the Body of Healthy Participants

Recruiting·Zealand Pharma·Phase 1·NCT06682975·124 enrolled

Plaque Psoriasis1 trial

An Interventional, Randomized, Double-blind, Placebo-controlled, Multiple Dose Trial Evaluating Safety, Tolerability, Pharmacokinetic, Pharmacodynamic, and Clinical Efficacy of ZP9830 Administered for 8 Weeks in Participants With Plaque Psoriasis

Recruiting·Zealand Pharma·Phase 1·NCT07733089·32 enrolled

Details

Drug Info

Related News